Product Information
DOXEPIN 50 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1463 per EA under NDC 64980059601. Its NADAC has been published 113 times since May 1, 2024.
Strength
50 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980059601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217975On Market Since
12/25/2023
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 50 MG CAPSULE has been published 113 times since May 1, 2024, and over the history we have for it it has declined 19.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1463 per EA |
|---|---|
| All-time high | $0.2049 (Jul 10, 2024) |
| All-time low | $0.1165 (Nov 20, 2024) |
| 52-week high | $0.1798 |
| 52-week low | $0.1441 |
| Median price | $0.1569 |
| Average price | $0.1607 |
| Largest weekly change | -37.5% (Nov 20, 2024) |
| Weeks tracked | 113 |
| Tracking since | May 1, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DOXEPIN 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 50 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.1463 per EA (NDC 64980059601), effective Jun 24, 2026.
How has the price of DOXEPIN 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 50 MG CAPSULE has declined 19.6%. It has been tracked across 113 weekly CMS publications since May 1, 2024.
What are the highest and lowest recorded NADAC prices for DOXEPIN 50 MG CAPSULE?
Since May 1, 2024, the NADAC for DOXEPIN 50 MG CAPSULE has ranged from a low of $0.1165 (Nov 20, 2024) to a high of $0.2049 (Jul 10, 2024), with a median of $0.1569 per EA.
Are there cheaper alternatives to DOXEPIN 50 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DOXEPIN 50 MG CAPSULE, but none are currently priced below it.
Who manufactures DOXEPIN 50 MG CAPSULE?
DOXEPIN 50 MG CAPSULE (NDC 64980059601) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification